Permanent focal cerebral ischemia activates erythropoietin receptor in the neonatal rat brain.
Erythropoietin (Epo) has been shown to act as a neurotrophic and neuroprotective factor via binding to its receptor (EpoR) which is activated in adult brains following hypoxia and ischemia. However, no evidence suggests that cerebral ischemia can activate EpoR in the neonatal brain. In the present study, the changes in EpoR expression were investigated using a modified model of permanent focal cerebral ischemia (FCI) in 7-day-old rat pups. Western blot analysis with an anti-rabbit EpoR antibody revealed a significant increase in the EpoR protein in the ischemic areas, starting from 6 to 12 h after FCI. Moreover, many EpoR-positive cells were detected in the ischemic areas from 12 h after FCI, and the positive cells were identified as neurons and microglia/macrophage but not astrocytes 24 h after FCI. Additionally, double staining with a red in situ apoptosis detection kit and the EpoR antibody indicated that EpoR-positive cells were in apoptotic cell death in the ischemic area. Therefore, these results suggest that EpoR is activated in the ischemic areas of neonatal rats and plays an important role in brain injury during development.
Wen
Tong-Chun
TC
Division of Neonatal-Perinatal Medicine, Department of Pediatrics, Emory University School of Medicine, 1462 Clifton Road, Atlanta, GA 30322, USA.
Rogido
Marta
M
Genetta
Tom
T
Sola
Augusto
A
D000818:Animals; D000831:Animals, Newborn / Q000378:metabolism*; D001921:Brain / Q000254:growth & development / Q000378:metabolism*; D002545:Brain Ischemia / Q000378:metabolism*; D005260:Female; D011247:Pregnancy; D051381:Rats; D017207:Rats, Sprague-Dawley; D017467:Receptors, Erythropoietin / Q000096:biosynthesis / Q000378:metabolism*
D017467:Receptors, Erythropoietin